World Oral Care Products: Dental Plaque - Pipeline Review, H2 2011

• Publication date: November 2011

This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. '' is built using data and information sourced from Global Industries Direct’s proprietary databases, Firms /University websites, SEC filings, investor presentations and featured press r...

This report provides information on the therapeutic development for Dental Plaque, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Plaque. '' is built using data and information sourced from Global Industries Direct’s proprietary databases, Firms /University websites, SEC filings, investor presentations and featured press releases from firm /university sites and market -specific third party sources, put together by Global Industries Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope of the Research

- A snapshot of the global therapeutic scenario for Dental Plaque.
- A review of the Dental Plaque products under development by industry players and universities/research institutes based on information derived from industry player and market -specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Dental Plaque pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Identify and understand important and diverse types of therapeutics under development for Dental Plaque.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and take over s effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Dental Plaque pipeline depth and focus of Dental Plaque therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and grow business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Global Oral Care Products Industry

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global March kets Direct Report Coverage 5
Dental Plaque Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Dental Plaque 7
Dental Plaque Therapeutics under Development by Firms 9
Dental Plaque Therapeutics under Investigation by Universities/Institutes 10
Mid Clinical Stage Products 11
Comparative Analysis 11
Early Clinical Stage Products 12
Comparative Analysis 12
Pre-Clinical Stage Products 13
Comparative Analysis 13
Dental Plaque Therapeutics - Products under Development by Firms 14
Dental Plaque Therapeutics - Products under Investigation by Universities/Institutes 15
Companies Involved in Dental Plaque Therapeutics Development 16
Aphios Corporation 16
Anacor Pharmaceuticals, Inc. 16
Dental Plaque - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Route of Administration 18
Assessment by Molecule Type 20
Drug Profiles 22
Pistacia Mutica - Drug Profile 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
AN0128 - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Asterias - Drug Profile 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Chlorhexidine Digluconate - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Green Propolis - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 28
Contact Us 28
Disclaimer 28

List of Tables

Number of Products Under Development for Dental Plaque, H2 2011 7
Products under Development for Dental Plaque – Comparative Analysis, H2 2011 8
Number of Products under Development by Firms, H2 2011 9
Number of Products under Investigation by Universities/Institutes, H2 2011 10
Comparative Analysis by Mid Clinical Stage Development, H2 2011 11
Comparative Analysis by Early Clinical Stage Development, H2 2011 12
Comparative Analysis by Pre-Clinical Stage Development, H2 2011 13
Products under Development by Firms, H2 2011 14
Products under Investigation by Universities/Institutes, H2 2011 15
Aphios Corporation, H2 2011 16
Anacor Pharmaceuticals, Inc., H2 2011 16
Assessment by Monotherapy Products, H2 2011 17
Assessment by Stage and Route of Administration, H2 2011 19
Assessment by Molecule Type, H2 2011 21

List of Figures

Number of Products under Development for Dental Plaque, H2 2011 7
Products under Development for Dental Plaque – Comparative Analysis, H2 2011 8
Products under Development by Firms, H2 2011 9
Products under Investigation by Universities/Institutes, H2 2011 10
Mid Clinical Stage Products, H2 2011 11
Early Clinical Stage Products, H2 2011 12
Pre-Clinical Stage Products, H2 2011 13
Assessment by Monotherapy Products, H2 2011 17
Assessment by Route of Administration, H2 2011 18
Assessment by Stage and Route of Administration, H2 2011 19
Assessment by Molecule Type, H2 2011 20
Assessment by Stage and Molecule Type, H2 2011 21